MT-3724
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for MT-3724, covering 2016-03-02 to 2022-08-18. Get the full timeline:
Most recent: Clinical Trial Update: Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL [Phase 1, Phase 2]